121 – 130 of 367
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Incidence of Nocturia in Men with Lower Urinary Tract Symptoms Associated with Benign Prostatic Enlargement and Outcomes After Medical Treatment : Results from the Evolution European Association of Urology Research Foundation Prospective Multinational Registry
(2019) In European Urology Focus
- Contribution to journal › Article
-
Mark
Agreement between patient reported outcomes and clinical reports after radical prostatectomy - A prospective longitudinal study
- Contribution to journal › Article
-
Mark
New Hope in Prostate Cancer Precision Medicine? miRNA Replacement and Epigenetics
- Contribution to journal › Debate/Note/Editorial
-
Mark
Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer
- Contribution to journal › Article
-
Mark
A registry-based study evaluating overall survival and treatment duration in Swedish patients with metastatic castration-resistant prostate cancer treated with enzalutamide
- Contribution to journal › Article
-
Mark
The STAT3 inhibitor galiellalactone inhibits the generation of MDSC-like monocytes by prostate cancer cells and decreases immunosuppressive and tumorigenic factors
- Contribution to journal › Article
-
Mark
90-Day readmission after radical prostatectomy—a prospective comparison between robot-assisted and open surgery
- Contribution to journal › Article
-
Mark
The β2-Adrenergic Receptor Is a Molecular Switch for Neuroendocrine Transdifferentiation of Prostate Cancer Cells
- Contribution to journal › Article
-
Mark
Health-related quality of life after apalutamide treatment in patients with metastatic castration-sensitive prostate cancer (TITAN) : a randomised, placebo-controlled, phase 3 study
- Contribution to journal › Article
- 2018
-
Mark
Plasma enterolactone and risk of prostate cancer in middle-aged Swedish men
- Contribution to journal › Article
